ORIC Pharmaceuticals, Inc.

US$8.82As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ORICHealthcare
Country USA
PE (Fwd) •••
TSR 7Y CAGR (15.49%)
Div yield —
ROE (39.80%)
Biotechnology
Beta (5Y) 1.22
PE TTM —
TSR TTM (32.98%)
Mkt cap US$914.2M
ROIC (27.13%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$8.54
(3.20%)
270.03%
Hold 12|4|8|0|2
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.18
0.20
0.19
0.19
13.67%
26.06%
12.56%
0.08%
Revenue$M
45.62
45.24
47.12
46.58
12.93%
5.80%
12.76%
5.27%
Peers (US$914.2M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.202
0.080
0.084
EBIT/Intx
3.029
0.159
0.154
Own earn%
(150.05)
(77.06)
(93.38)
Sh yield%
42.90
54.91
52.68
Owners
Insiders/Inst%
10.95
46.26
Short interest%
4.00
SBC / revenue%
1.14
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
0–5
$1 testx
0.0
Incr. ROIC%
4